Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy

Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy

Purpose: Approximately 7% of patients with newly diagnosed prostate cancer (PCa) in the US will have have metastatic disease. The dogma that there is no role for surgery in this population has been questioned recently. Here we report long-term outcomes of a phase 1 clinical trial on cytoreductive ra...

Full description

Bibliographic Details
Main Authors: Isaac Yi Kim, Antonina Mitrofanova, Sukanya Panja, Joshua Sterling, Arnav Srivastava, Juliana Kim, Sinae Kim, Eric A. Singer, Thomas L. Jang, Saum Ghodoussipour, Biren Saraiya, Tina Mayer, Hatem E. Sabaawy, Bertram Yuh, Seok Soo Byun, Wun-Jae Kim, Shigeo Horie
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Prostate International
Subjects:
Prostate cancer
Metastasis
Cytoreduction
Clinical trial
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888222000137

Internet

http://www.sciencedirect.com/science/article/pii/S2287888222000137

Similar Items